Actonel Related Clinical Trials
Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects [Completed]
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD [Completed]
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer [Active, not recruiting]
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children [Active, not recruiting]
Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy [Completed]
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis [Completed]
A Study of Monthly Risedronate for Osteoporosis [Completed]
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate [Completed]
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone [Recruiting]
A Study to Show That Treatment With Denosumab is as Good as Treatment With Risedronate in Subjects Who Are Starting to Take or Currently Taking Glucocorticoids. [Recruiting]
Effect of Actonel on Periodontal Health of Postmenopausal Women [Recruiting]
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis [Recruiting]
Pharmacokinetics of a Single 14C-Labeled Dose of Risedronate or Alendronate Followed by Once-a-Week Unlabeled Oral Dose [Completed]
Study to Evaluate the Safety and Efficacy of Denosumab and ActonelŽ in Post Menopausal Women Transitioned From Alendronate Therapy [Recruiting]
Risedronate Sodium in Post Menopausal Osteoporosis [Completed]
IGF-1 and Bone Loss in Women With Anorexia Nervosa [Recruiting]
Satisfaction and Compliance of Risedronate in PMO [Completed]
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [Completed]
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis [Active, not recruiting]
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy [Active, not recruiting]
POWER Point of Care Effect on Satisfaction of Treatment [Completed]
A Study of Actonel for the Prevention of Bone Loss [Recruiting]
Risedronate in Osteopenic Postmenopausal Women [Active, not recruiting]
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects [Recruiting]
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis [Active, not recruiting]
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO [Completed]
Food Effects on the Relative Bioavailability of Different Dosages of Risedronate [Recruiting]
Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women [Completed]
SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture. [Recruiting]
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. [Active, not recruiting]
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis [Completed]
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer [Completed]
ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week [Terminated]
Risedronate in Postmenopausal Women With Low Bone Density [Completed]
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer [Recruiting]
Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone [Active, not recruiting]
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women [Completed]
Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [Completed]
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis [Recruiting]
Prevention of Osteoporosis in Breast Cancer Survivors [Completed]
Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. [Completed]
Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury [Active, not recruiting]
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use [Recruiting]
A Study That Will Compare the Effect of Two Drugs on Patients With Low Bone Mass and a Recent Hip Fracture [Recruiting]
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS [Recruiting]
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. [Active, not recruiting]
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study) [Active, not recruiting]
IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) [Completed]
The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment [Completed]
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy [Recruiting]
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer [Active, not recruiting]
New Bisphosphonate Treatment for Paget's Disease [Active, not recruiting]
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method [Active, not recruiting]
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis [Recruiting]
Bone Microarchitecture in Osteopenic Postmenopausal Women [Recruiting]
Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis [Recruiting]
A Study to Evaluate and Compare the Effects of Two Approved Drugs in Women With Postmenopausal Osteoporosis
A Study to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis [Completed]
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. [Active, not recruiting]
Bone Loss in Women With Anorexia Nervosa [Recruiting]
Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis [Recruiting]
Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM) [Recruiting]
Vitamin K and Bone Turnover in Postmenopausal Women [Completed]
Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients [Active, not recruiting]
VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy [Recruiting]
Main Trial: Nitrates and Bone Turnover: Trial to Select the Best Nitrate Preparation; Sub-Study: Nitrates and Bone Turnover Bisphosphonate Sub-Study [Recruiting]
Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis [Completed]
|
